Poland – Various medicinal products – Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba.

Opportunity description

A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form - Packages Nos. 1–26. Package No. 1: Heparins, Package No. 2: Parenteral nutrition products, Package No. 3: Infusion fluids, Package No. 4: Various medicines 1, Package No. 5: Various medicines 2, Package No. 6: Various medicines 3, Package No. 7: Albumins/Immunoglobulins, Package No. 8: Lorazepam, Package No. 9: Human anti-D immunoglobulin [1], Package No. 10: Human anti-D immunoglobulin [2], Package No. 11: Nutrition products for infants, children and adults, Package No. 12: Various medicines 4, Package No. 13: Various medicines 5, Package No. 14: Various medicines 6, Package No. 15: Various medicines 7, Package No. 16: Various medicines 8, Package No. 17: Enteral nutrition products, Package No. 18: Various medicines 9, Package No. 19: Paliperidone, Package No. 20: Omeprazole/Pantoprazole, Package No. 21: Various medicines 10, Package No. 22: Various medicines 11, Package No. 23: Various medicines 12, Package No. 24: Propofol +EDTA, Package No. 25: Propofol, Package No. 26: Renal therapy products. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2 due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the option to change the quantity of the product ordered within the quantities specified in individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. The remaining conditions concerning performance of the contract have been specified in the Model contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In such an item, the appropriate trade name and the product’s EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority specified the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterises the products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favoured or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Pzp Act, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall be understood as a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, threshold parameters. The term “parameters” means functionality, intended use, colour scheme, structure, materials, shape, size, safety, durability, etc. h) In view of the above, the Contracting Authority permits the option of offering materials with different trademarks, patents or origins, but not with properties and functionality different from those specified in the SWZ. i) Whenever a standard is indicated in this SWZ or the annexes to the SWZ, it shall be assumed that the phrase “or equivalent” has been used in relation to it. j) If the Contractor does not submit documents in its tender concerning the use of other materials and equipment, this shall be understood to mean that the materials and equipment proposed in the description of the subject matter of the contract have been included in the calculation of the tender price and in the performance of the contract. The Contracting Authority permits the submission of tenders for all parts of the contract, divided into individual Packages from 1 to 26 (none of the Packages may be subdivided). Articles classified as a medicinal product – within the meaning of the Pharmaceutical Law Act of 06 September 2001 (Journal of Laws of 2026, item 612, as amended) – must be authorised for marketing in the territory of the Republic of Poland in accordance with the provisions of that Act and possess the appropriate documents (if the law requires possession of such documents). Medical articles classified as a medical device must possess documents permitting marketing and use in accordance with the Act of 07 April 2022 on medical devices (Journal of Laws of 2024, item 1620), i.e. CE certificates, declarations of conformity, registration certificates – to the extent appropriate to the procedure in question (if the law requires possession of such documents). The contract performance period shall run from the effective date of the contract ……………… to 31.07.2027 or until the quantities of the assortment specified in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form – have been used, whichever occurs first. I. Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba. A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form, Package No. 1: Heparins. Number of assortment items: 7. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2 due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the option to change the quantity of the product ordered within the quantities specified in individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. The remaining conditions concerning performance of the contract have been specified in the Model contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. II. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In such an item, the appropriate trade name and the product’s EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority specified the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterises the products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favoured or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Pzp Act, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall be understood as a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, threshold parameters. The term “parameters” means functionality, intended use, colour scheme, structure, materials, shape, size, safety, durability, etc. h) In view of the above, the Contracting Authority permits the option of offering materials with different trademarks, patents or origins, but not with properties and functionality different from those specified in the SWZ. i) Whenever a standard is indicated in this SWZ or the annexes to the SWZ, it shall be assumed that the phrase “or equivalent” has been used in relation to it. j) If the Contractor does not submit documents in its tender concerning the use of other materials and equipment, this shall be understood to mean that the materials and equipment proposed in the description of the subject matter of the contract have been included in the calculation of the tender price and in the performance of the contract. III. A) Articles classified as a medicinal product – within the meaning of the Pharmaceutical Law Act of 06 September 2001 (Journal of Laws of 2026, item 612, as amended) – must be authorised for marketing in the territory of the Republic of Poland in accordance with the provisions of that Act and possess the appropriate documents (if the law requires possession of such documents). B) Medical articles classified as a medical device must possess documents permitting marketing and use in accordance with the Act of 07 April 2022 on medical devices (Journal of Laws of 2024, item 1620), i.e. CE certificates, declarations of conformity, registration certificates – to the extent appropriate to the procedure in question (if the law requires possession of such documents). IV. The contract performance period shall run from the effective date of the contract ……………… to 31.07.2027 or until the quantities of the assortment specified in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form – have been used, whichever occurs first. The indication of the supply completion date is justified by an objective reason: supplies will be made successively, the contract completion date was specified in order to maintain continuity of supply, and the completion of contracts on the same date for a given type of assortment is intended to maintain continuity of those contracts and also enables the timely performance of the Contracting Authority’s tasks. V. The Contracting Authority permits the submission of tenders for all parts of the contract, divided into individual Packages from 1 to 26 (none of the Packages may be subdivided). VI. The Contracting Authority permits amendment of the concluded contract during its performance in the cases specified in the Model contract - Annex No. 4 to the SWZ. VII. SUBJECT-MATTER EVIDENCE - in accordance with Chapter XII of the SWZ. I. Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba. A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form, Package No. 2: Parenteral nutrition products. Number of assortment items: 23. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2 due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the option to change the quantity of the product ordered within the quantities specified in individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. For the assortment from Package No. 2 – on a loan-for-use basis – an AMBIX ACTIV/NOVA-type pump for parenteral nutrition, quantity 3 units, for the duration of the contract – under the terms specified in Annex No. 1 to the Model contract constituting Annex No. 4 to the SWZ. The remaining conditions concerning performance of the contract have been specified in the Model contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. II. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In such an item, the appropriate trade name and the product’s EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority specified the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterises the products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favoured or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Pzp Act, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall be understood as a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, threshold parameters. The term “parameters” means functionality, intended use, colour scheme, structure, materials, shape, size, safety, durability, etc. h) In view of the above, the Contracting Authority permits the option of offering materials with different trademarks, patents or origins, but not with properties and functionality different from those specified in the SWZ. i) Whenever a standard is indicated in this SWZ or the annexes to the SWZ, it shall be assumed that the phrase “or equivalent” has been used in relation to it. j) If the Contractor does not submit documents in its tender concerning the use of other materials and equipment, this shall be understood to mean that the materials and equipment proposed in the description of the subject matter of the contract have been included in the calculation of the tender price and in the performance of the contract. III. A) Articles classified as a medicinal product – within the meaning of the Pharmaceutical Law Act of 06 September 2001 (Journal of Laws of 2026, item 612, as amended) – must be authorised for marketing in the territory of the Republic of Poland in accordance with the provisions of that Act and possess the appropriate documents (if the law requires possession of such documents). B) Medical articles classified as a medical device must possess documents permitting marketing and use in accordance with the Act of 07 April 2022 on medical devices (Journal of Laws of 2024, item 1620), i.e. CE certificates, declarations of conformity, registration certificates – to the extent appropriate to the procedure in question (if the law requires possession of such documents). IV. The contract performance period shall run from the effective date of the contract ……………… to 31.07.2027 or until the quantities of the assortment specified in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form – have been used, whichever occurs first. The indication of the supply completion date is justified by an objective reason: supplies will be made successively, the contract completion date was specified in order to maintain continuity of supply, and the completion of contracts on the same date for a given type of assortment is intended to maintain continuity of those contracts and also enables the timely performance of the Contracting Authority’s tasks. V. The Contracting Authority permits the submission of tenders for all parts of the contract, divided into individual Packages from 1 to 26 (none of the Packages may be subdivided). VI. The Contracting Authority permits amendment of the concluded contract during its performance in the cases specified in the Model contract - Annex No. 4 to the SWZ. I. Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba. A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form, Package No. 3: Infusion fluids. Number of assortment items: 32. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2 due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the option to change the quantity of the product ordered within the quantities specified in individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. The remaining conditions concerning performance of the contract have been specified in the Model contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. II. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In such an item, the appropriate trade name and the product’s EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority specified the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterises the products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favoured or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Pzp Act, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall be understood as a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, threshold parameters. The term “parameters” means functionality, intended use, colour scheme, structure, materials, shape, size, safety, durability, etc. h) In view of the above, the Contracting Authority permits the option of offering materials with different trademarks, patents or origins, but not with properties and functionality different from those specified in the SWZ. i) Whenever a standard is indicated in this SWZ or the annexes to the SWZ, it shall be assumed that the phrase “or equivalent” has been used in relation to it. j) If the Contractor does not submit documents in its tender concerning the use of other materials and equipment, this shall be understood to mean that the materials and equipment proposed in the description of the subject matter of the contract have been included in the calculation of the tender price and in the performance of the contract. III. A) Articles classified as a medicinal product – within the meaning of the Pharmaceutical Law Act of 06 September 2001 (Journal of Laws of 2026, item 612, as amended) – must be authorised for marketing in the territory of the Republic of Poland in accordance with the provisions of that Act and possess the appropriate documents (if the law requires possession of such documents). B) Medical articles classified as a medical device must possess documents permitting marketing and use in accordance with the Act of 07 April 2022 on medical devices (Journal of Laws of 2024, item 1620), i.e. CE certificates, declarations of conformity, registration certificates – to the extent appropriate to the procedure in question (if the law requires possession of such documents). IV. The contract performance period shall run from the effective date of the contract ……………… to 31.07.2027 or until the quantities of the assortment specified in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form – have been used, whichever occurs first. The indication of the supply completion date is justified by an objective reason: supplies will be made successively, the contract completion date was specified in order to maintain continuity of supply, and the completion of contracts on the same date for a given type of assortment is intended to maintain continuity of those contracts and also enables the timely performance of the Contracting Authority’s tasks. V. The Contracting Authority permits the submission of tenders for all parts of the contract, divided into individual Packages from 1 to 26 (none of the Packages may be subdivided). VI. The Contracting Authority permits amendment of the concluded contract during its performance in the cases specified in the Model contract - Annex No. 4 to the SWZ. I. Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba. A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form, Package No. 4: Various medicines 1. Number of assortment items: 51. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2 due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the option to change the quantity of the product ordered within the quantities specified in individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. The remaining conditions concerning performance of the contract have been specified in the Model contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. II. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In such an item, the appropriate trade name and the product’s EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority specified the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterises the products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favoured or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Pzp Act, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall be understood as a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, threshold parameters. The term “parameters” means functionality, intended use, colour scheme, structure, materials, shape, size, safety, durability, etc. h) In view of the above, the Contracting Authority permits the option of offering materials with different trademarks, patents or origins, but not with properties and functionality different from those specified in the SWZ. i) Whenever a standard is indicated in this SWZ or the annexes to the SWZ, it shall be assumed that the phrase “or equivalent” has been used in relation to it. j) If the Contractor does not submit documents in its tender concerning the use of other materials and equipment, this shall be understood to mean that the materials and equipment proposed in the description of the subject matter of the contract have been included in the calculation of the tender price and in the performance of the contract. III. A) Articles classified as a medicinal product – within the meaning of the Pharmaceutical Law Act of 06 September 2001 (Journal of Laws of 2026, item 612, as amended) – must be authorised for marketing in the territory of the Republic of Poland in accordance with the provisions of that Act and possess the appropriate documents (if the law requires possession of such documents). B) Medical articles classified as a medical device must possess documents permitting marketing and use in accordance with the Act of 07 April 2022 on medical devices (Journal of Laws of 2024, item 1620), i.e. CE certificates, declarations of conformity, registration certificates – to the extent appropriate to the procedure in question (if the law requires possession of such documents). IV. The contract performance period shall run from the effective date of the contract ……………… to 31.07.2027 or until the quantities of the assortment specified in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form – have been used, whichever occurs first. The indication of the supply completion date is justified by an objective reason: supplies will be made successively, the contract completion date was specified in order to maintain continuity of supply, and the completion of contracts on the same date for a given type of assortment is intended to maintain continuity of those contracts and also enables the timely performance of the Contracting Authority’s tasks. V. The Contracting Authority permits the submission of tenders for all parts of the contract, divided into individual Packages from 1 to 26 (none of the Packages may be subdivided). VI. The Contracting Authority permits amendment of the concluded contract during its performance in the cases specified in the Model contract - Annex No. 4 to the SWZ. I. Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba. A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form, Package No. 5: Various medicines 2. Number of assortment items: 11. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2 due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the option to change the quantity of the product ordered within the quantities specified in individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. The remaining conditions concerning performance of the contract have been specified in the Model contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. II. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In such an item, the appropriate trade name and the product’s EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority specified the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterises the products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favoured or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Pzp Act, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall be understood as a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, threshold parameters. The term “parameters” means functionality, intended use, colour scheme, structure, materials, shape, size, safety, durability, etc. h) In view of the above, the Contracting Authority permits the option of offering materials with different trademarks, patents or origins, but not with properties and functionality different from those specified in the SWZ. i) Whenever a standard is indicated in this SWZ or the annexes to the SWZ, it shall be assumed that the phrase “or equivalent” has been used in relation to it. j) If the Contractor does not submit documents in its tender concerning the use of other materials and equipment, this shall be understood to mean that the materials and equipment proposed in the description of the subject matter of the contract have been included in the calculation of the tender price and in the performance of the contract. III. A) Articles classified as a medicinal product – within the meaning of the Pharmaceutical Law Act of 06 September 2001 (Journal of Laws of 2026, item 612, as amended) – must be authorised for marketing in the territory of the Republic of Poland in accordance with the provisions of that Act and possess the appropriate documents (if the law requires possession of such documents). B) Medical articles classified as a medical device must possess documents permitting marketing and use in accordance with the Act of 07 April 2022 on medical devices (Journal of Laws of 2024, item 1620), i.e. CE certificates, declarations of conformity, registration certificates – to the extent appropriate to the procedure in question (if the law requires possession of such documents). IV. The contract performance period shall run from the effective date of the contract ……………… to 31.07.2027 or until the quantities of the assortment specified in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form – have been used, whichever occurs first. The indication of the supply completion date is justified by an objective reason: supplies will be made successively, the contract completion date was specified in order to maintain continuity of supply, and the completion of contracts on the same date for a given type of assortment is intended to maintain continuity of those contracts and also enables the timely performance of the Contracting Authority’s tasks. V. The Contracting Authority permits the submission of tenders for all parts of the contract, divided into individual Packages from 1 to 26 (none of the Packages may be subdivided). VI. The Contracting Authority permits amendment of the concluded contract during its performance in the cases specified in the Model contract - Annex No. 4 to the SWZ. I. Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba. A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form, Package No. 6: Various medicines 3. Number of assortment items: 143. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2 due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the option to change the quantity of the product ordered within the quantities specified in individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. The remaining conditions concerning performance of the contract have been specified in the Model contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. II. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In such an item, the appropriate trade name and the product’s EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority specified the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterises the products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favoured or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Pzp Act, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall be understood as a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, threshold parameters. The term “parameters” means functionality, intended use, colour scheme, structure, materials, shape, size, safety, durability, etc. h) In view of the above, the Contracting Authority permits the option of offering materials with different trademarks, patents or origins, but not with properties and functionality different from those specified in the SWZ. i) Whenever a standard is indicated in this SWZ or the annexes to the SWZ, it shall be assumed that the phrase “or equivalent” has been used in relation to it. j) If the Contractor does not submit documents in its tender concerning the use of other materials and equipment, this shall be understood to mean that the materials and equipment proposed in the description of the subject matter of the contract have been included in the calculation of the tender price and in the performance of the contract. III. A) Articles classified as a medicinal product – within the meaning of the Pharmaceutical Law Act of 06 September 2001 (Journal of Laws of 2026, item 612, as amended) – must be authorised for marketing in the territory of the Republic of Poland in accordance with the provisions of that Act and possess the appropriate documents (if the law requires possession of such documents). B) Medical articles classified as a medical device must possess documents permitting marketing and use in accordance with the Act of 07 April 2022 on medical devices (Journal of Laws of 2024, item 1620), i.e. CE certificates, declarations of conformity, registration certificates – to the extent appropriate to the procedure in question (if the law requires possession of such documents). IV. The contract performance period shall run from the effective date of the contract ……………… to 31.07.2027 or until the quantities of the assortment specified in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form – have been used, whichever occurs first. The indication of the supply completion date is justified by an objective reason: supplies will be made successively, the contract completion date was specified in order to maintain continuity of supply, and the completion of contracts on the same date for a given type of assortment is intended to maintain continuity of those contracts and also enables the timely performance of the Contracting Authority’s tasks. V. The Contracting Authority permits the submission of tenders for all parts of the contract, divided into individual Packages from 1 to 26 (none of the Packages may be subdivided). VI. The Contracting Authority permits amendment of the concluded contract during its performance in the cases specified in the Model contract - Annex No. 4 to the SWZ. I. Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba. A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form, Package No. 7: Albumins/Immunoglobulins. Number of assortment items: 5. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2 due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the option to change the quantity of the product ordered within the quantities specified in individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. The remaining conditions concerning performance of the contract have been specified in the Model contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. II. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In such an item, the appropriate trade name and the product’s EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority specified the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterises the products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favoured or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Pzp Act, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall be understood as a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, threshold parameters. The term “parameters” means functionality, intended use, colour scheme, structure, materials, shape, size, safety, durability, etc. h) In view of the above, the Contracting Authority permits the option of offering materials with different trademarks, patents or origins, but not with properties and functionality different from those specified in the SWZ. i) Whenever a standard is indicated in this SWZ or the annexes to the SWZ, it shall be assumed that the phrase “or equivalent” has been used in relation to it. j) If the Contractor does not submit documents in its tender concerning the use of other materials and equipment, this shall be understood to mean that the materials and equipment proposed in the description of the subject matter of the contract have been included in the calculation of the tender price and in the performance of the contract. III. A) Articles classified as a medicinal product – within the meaning of the Pharmaceutical Law Act of 06 September 2001 (Journal of Laws of 2026, item 612, as amended) – must be authorised for marketing in the territory of the Republic of Poland in accordance with the provisions of that Act and possess the appropriate documents (if the law requires possession of such documents). B) Medical articles classified as a medical device must possess documents permitting marketing and use in accordance with the Act of 07 April 2022 on medical devices (Journal of Laws of 2024, item 1620), i.e. CE certificates, declarations of conformity, registration certificates – to the extent appropriate to the procedure in question (if the law requires possession of such documents). IV. The contract performance period shall run from the effective date of the contract ……………… to 31.07.2027 or until the quantities of the assortment specified in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form – have been used, whichever occurs first. The indication of the supply completion date is justified by an objective reason: supplies will be made successively, the contract completion date was specified in order to maintain continuity of supply, and the completion of contracts on the same date for a given type of assortment is intended to maintain continuity of those contracts and also enables the timely performance of the Contracting Authority’s tasks. V. The Contracting Authority permits the submission of tenders for all parts of the contract, divided into individual Packages from 1 to 26 (none of the Packages may be subdivided). VI. The Contracting Authority permits amendment of the concluded contract during its performance in the cases specified in the Model contract - Annex No. 4 to the SWZ. I. Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba. A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form, Package No. 9: Human anti-D immunoglobulin [1]. Number of assortment items: 2. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2 due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the option to change the quantity of the product ordered within the quantities specified in individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. The remaining conditions concerning performance of the contract have been specified in the Model contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. II. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In such an item, the appropriate trade name and the product’s EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority specified the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterises the products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favoured or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Pzp Act, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall be understood as a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, threshold parameters. The term “parameters” means functionality, intended use, colour scheme, structure, materials, shape, size, safety, durability, etc. h) In view of the above, the Contracting Authority permits the option of offering materials with different trademarks, patents or origins, but not with properties and functionality different from those specified in the SWZ. i) Whenever a standard is indicated in this SWZ or the annexes to the SWZ, it shall be assumed that the phrase “or equivalent” has been used in relation to it. j) If the Contractor does not submit documents in its tender concerning the use of other materials and equipment, this shall be understood to mean that the materials and equipment proposed in the description of the subject matter of the contract have been included in the calculation of the tender price and in the performance of the contract. III. A) Articles classified as a medicinal product – within the meaning of the Pharmaceutical Law Act of 06 September 2001 (Journal of Laws of 2026, item 612, as amended) – must be authorised for marketing in the territory of the Republic of Poland in accordance with the provisions of that Act and possess the appropriate documents (if the law requires possession of such documents). B) Medical articles classified as a medical device must possess documents permitting marketing and use in accordance with the Act of 07 April 2022 on medical devices (Journal of Laws of 2024, item 1620), i.e. CE certificates, declarations of conformity, registration certificates – to the extent appropriate to the procedure in question (if the law requires possession of such documents). IV. The contract performance period shall run from the effective date of the contract ……………… to 31.07.2027 or until the quantities of the assortment specified in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form – have been used, whichever occurs first. The indication of the supply completion date is justified by an objective reason: supplies will be made successively, the contract completion date was specified in order to maintain continuity of supply, and the completion of contracts on the same date for a given type of assortment is intended to maintain continuity of those contracts and also enables the timely performance of the Contracting Authority’s tasks. V. The Contracting Authority permits the submission of tenders for all parts of the contract, divided into individual Packages from 1 to 26 (none of the Packages may be subdivided). VI. The Contracting Authority permits amendment of the concluded contract during its performance in the cases specified in the Model contract - Annex No. 4 to the SWZ. I. Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba. A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form, Package No. 14: Various medicines 6. Number of assortment items: 10. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2 due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the option to change the quantity of the product ordered within the quantities specified in individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. The remaining conditions concerning performance of the contract have been specified in the Model contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. II. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In such an item, the appropriate trade name and the product’s EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority specified the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterises the products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favoured or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Pzp Act, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall be understood as a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, threshold parameters. The term “parameters” is…